🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
IMM
$IMMX
🔒 US EquitiesImmix Biopharma Inc
AVG HISTORICAL GAP
-1.00%
MAX GAP RECORD
-8.75%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $IMMX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$IMMX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 07, 2026 Earnings Release 2026-08-07 (AFTER CLOSE) |
+0.36%
|
| Mar 25, 2026 Earnings Release 2026-03-25 (AFTER CLOSE) |
-8.75%
|
| Nov 07, 2025 Earnings Release 2025-11-07 (AFTER CLOSE) |
+3.49%
|
| Aug 08, 2025 Earnings Release 2025-08-08 (AFTER CLOSE) |
+0.00%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
-3.30%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-1.74%
|
| Aug 12, 2024 Earnings Release 2024-08-12 (AFTER CLOSE) |
+0.00%
|
| Mar 28, 2024 Earnings Release 2024-03-28 (AFTER CLOSE) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.6%
Bullish Gaps (2)
Bearish Gaps (5)
Neutral / Flat (2)
📖 Intelligence Summary
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗